Camelot Portfolios LLC Buys Shares of 2,263 Humana Inc. (NYSE:HUM)

Camelot Portfolios LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,263 shares of the insurance provider’s stock, valued at approximately $574,000.

Other hedge funds have also made changes to their positions in the company. Peregrine Asset Advisers Inc. acquired a new stake in shares of Humana in the 4th quarter worth $4,327,000. Transcend Capital Advisors LLC lifted its holdings in Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after acquiring an additional 2,914 shares during the period. Paradigm Asset Management Co. LLC grew its position in Humana by 766.7% during the fourth quarter. Paradigm Asset Management Co. LLC now owns 2,600 shares of the insurance provider’s stock valued at $660,000 after buying an additional 2,300 shares during the period. Centricity Wealth Management LLC acquired a new position in shares of Humana during the 4th quarter worth approximately $30,000. Finally, RPS Advisory Solutions LLC purchased a new position in Humana in the 4th quarter valued at about $386,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. JPMorgan Chase & Co. lowered their target price on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Morgan Stanley reduced their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. TD Cowen increased their target price on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Finally, Barclays increased their target price on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $285.68.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.32% of the stock is currently owned by corporate insiders.

Humana Trading Down 5.7 %

Shares of HUM stock opened at $255.77 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The stock has a market cap of $30.80 billion, a P/E ratio of 25.71, a price-to-earnings-growth ratio of 2.00 and a beta of 0.56. The stock has a 50 day simple moving average of $269.41 and a 200 day simple moving average of $290.45.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.38%. Humana’s dividend payout ratio is currently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.